Advantage Alpha Capital Partners LP Ligand Pharmaceuticals Inc Transaction History
Advantage Alpha Capital Partners LP
- $337 Million
- Q2 2025
A detailed history of Advantage Alpha Capital Partners LP transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Advantage Alpha Capital Partners LP holds 1,823 shares of LGND stock, worth $328,358. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,823Holding current value
$328,358% of portfolio
0.06%Shares
1 transactions
Others Institutions Holding LGND
# of Institutions
290Shares Held
19.5MCall Options Held
9KPut Options Held
0-
Black Rock Inc. New York, NY2.87MShares$517 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.09MShares$376 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X01.06MShares$191 Million0.06% of portfolio
-
Macquarie Group LTD Australia, C3927KShares$167 Million0.13% of portfolio
-
State Street Corp Boston, MA750KShares$135 Million0.0% of portfolio
About LIGAND PHARMACEUTICALS INC
- Ticker LGND
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 16,882,800
- Market Cap $3.04B
- Description
- Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...